Moderna Signs US$1.8 B Oncology Collaboration with Immatics

By Lucy Haggerty

Pharma Deals Review: Vol 2023 Issue 9 (Table of Contents)

Published: 15 Sep-2023

DOI: 10.3833/pdr.v2023.i9.2804     ISSN: 1756-7874

Section: Licensing



In an attempt to diversify its portfolio, Moderna has entered into a strategic multi-platform collaboration with Immatics to develop new therapies for cancer patients with high unmet need...

This page is available to subscribers only.

Not a subscriber? Join here

Why should I subscribe?

Already Registered? Please login using the top left purple box.

Copyright: © IQVIA 2018

IQVIA™ Pharma Deals: PharmaDeals Review: Article Details